US Stocks
/
CalciMedica, Inc. Share Price

CalciMedica, Inc. Share Price

NASDAQ: CALC | Micro Cap
$0.66
-$0.02 (-3.26%) Last updated on 11 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

CalciMedica, Inc. Stock Performance

Open
$0.67
Prev. Close
$0.69
Circuit Range
N/A
Day Range
$0.65 - $0.68
Year Range
$0.49 - $6.79
Volume
4,137
Average Traded
$0.66

CalciMedica, Inc. Share Price Today

As of 11 August 2026, CalciMedica, Inc.'s share price is $0.66. The stock opened at $0.67, compared to its previous close of $0.69. During today's trading session, CalciMedica, Inc.'s share price traded between $0.65 and $0.68, with an average price of $0.66. Over the past 52 weeks, the stock has recorded a high of $6.79 and a low of $0.49. In terms of performance, CalciMedica, Inc.'s share price has risen by 27.93% over the last six months and is down 75.36% on a year-on-year basis.

CalciMedica, Inc. Share Price Chart

$0.65$0.68
L
Show Current Price
H

CalciMedica, Inc. Stock Fundamentals & Key Indicators

Market Cap
$9.95M
PE Ratio (TTM)
-0.34
Dividend Yield
N/A
EPS (TTM)
$-1.97
Revenue (TTM)
N/A
Return On Equity (TTM)
445.14%
Profit Margin
N/A
Debt to Equity
-0.57
Quarterly Earnings Growth YoY
-38.91%

CalciMedica, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit$130000.00-$3.95M-$5.62M-$5.04M-$5.96M-$7.80M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-3141.54%-42.08%10.25%-18.13%-31.03%

CalciMedica, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
RevenueN/AN/A
Net Profit-$13.70M-$29.56M
Net Profit MarginN/AN/A
Income ChangeN/A-115.78%

About CalciMedica, Inc.

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.

CalciMedica, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.96
$0.66
-32.45%
Jul 2026
$0.98
$0.98
+0.20%
Jun 2026
$0.85
$0.98
+25.38%
May 2026
$0.61
$0.78
+36.84%
Apr 2026
$0.59
$0.57
+5.56%
Mar 2026
$0.49
$0.54
+4.25%
Feb 2026
$0.78
$0.52
-42.12%
Jan 2026
$6.63
$0.90
-86.56%
Dec 2025
$4.34
$6.66
+57.82%
Nov 2025
$3.00
$4.22
+42.57%
Oct 2025
$3.15
$2.96
-5.73%
Sep 2025
$2.90
$3.14
+16.73%

CALC Share Price FAQs

What is CalciMedica, Inc. share price today?

chevron-up
CalciMedica, Inc. share price today is $0.66 as on August 11, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of CalciMedica, Inc. stock?

chevron-up
The 52 week high of CalciMedica, Inc. stock is $6.79, while the 52 week low is $0.49 as of 11 Aug '26.

What is CALC's market capitalisation today?

chevron-up
CALC market capitalisation is $9.95M as of August 11, 2026, at 8:13 am IST.

What is CALC's net income for the last quarter?

chevron-up
CALC's net income for the last quarter is -0.01B USD.

What is the 5 year returns of CALC?

chevron-up
The 5 year returns of CALC is -87.21% as on 11 Aug '26.

What is the high & low stock price of CALC today?

chevron-up
CALC stock price hit a high of $0.68 and low of $0.65 as of 11 Aug '26.

Can I buy CALC shares in India?

chevron-up
Yes. You can buy CALC in India by opening an international trading account.